Questions? Call 888-624-8373

PAPERBACK
list:$101.50
Web:$91.35
add to cart

Rights & Permissions

Free PDF Access

Related Titles

topleft topright

Toxicological Risks of Selected Flame-Retardant Chemicals (2000)
Commission on Life Sciences (CLS)

Page
254
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Toxicological Risks of Selected Flame-Retardant Chemicals

TABLE 10–8 Results of Modeling for the Watt (1983) Study on Antimony Trioxide

 

Multistage model (mg/m3)

Risk by EPA methods (mg/m3)−1

End point

ED10

LED10

0.1/ED10

0.1/LED10

Adenomas

0.51

0.24

0.185

0.417

Scirrhous carcinomas

0.35

0.21

0.286

0.476

Squamous-cell carcinomas

0.83

0.43

0.120

0.233

Bronchioalveolar tumor (combined)

0.24

0.14

0.417

0.714

ED10, effective dose corresponding to a 10% tumor response in test animals; LED10, lower 95% bound on the effective dose corresponding to a 10% tumor response in test animals.

adult spends 1/4th of his or her time sitting on furniture upholstery treated with antimony trioxide, that 1/4th of the upper torso is in contact with the upholstery, and that clothing presents no barrier. Antimony trioxide is considered to be ionic, and is essentially not absorbed through the skin. However, to be conservative, the subcommittee assumed that ionized antimony trioxide permeates the skin at the same rate as water, with a permeability rate of 10−3 cm/hr (EPA 1992). Using that permeability rate, the highest expected application rate for antimony trioxide (2.5 mg/cm2), and Equation 1 in Chapter 3, the subcommittee calculated a dermal exposure level of 2.0×10−2 mg/kg-d. The oral RfD for antimony trioxide (0.2 mg/kg-d; see Oral RfD in Quantitative Toxicity section) was used as the best estimate of the internal dose for dermal exposure. Dividing the exposure level by the oral RfD yields a hazard index of 0.1. Thus it was concluded that antimony trioxide used as a flame retardant in upholstery fabric is not likely to pose a noncancer risk by the dermal route.

Inhalation
Particles

The assessment of the noncancer risk by the inhalation route of exposure is based on the scenario described Chapter 3. This scenario corresponds to a person spending 1/4th of his or her life in a room with low air-change rate

Page
254